Skip to main content
Lowell Anthony, MD, Oncology, Lexington, KY

LowellBrianAnthonyMD

Oncology Lexington, KY

Gastrointestinal Cancer, Hematologic Oncology

Chief, Medical Oncology, Professor of Medicine, University of Kentucky College of Medicine, Markey Cancer Center

Dr. Anthony is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Anthony's full profile

Already have an account?

  • Office

    800 Rose Street, CC454
    University of Kentucky Medical Center
    Lexington, KY 40536
    Phone+1 859-323-6522
    Fax+1 859-257-7715

Summary

  • Dr. Lowell Anthony is an oncologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 38 years. He specializes in gastrointestinal cancer and early phase (I and II) clinical trials. His major ongoing focus is with neuroendocrine neoplasms that include carcinoids, pancreatic islet cell tumors and theranostics by using somatostatin receptor imaging to predict therapeutic benefit.
  • Lowell Anthony, MD - UK HealthCare

    Dr. Lowell Anthony speaks about how he likes working at Markey Cancer Center because of the multidisciplinary approach providers take to treat patients. For ...

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Clinical Pharmacology, 1985 - 1987
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1979 - 1982
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1979

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2011 - 2025
  • TN State Medical License
    TN State Medical License 1981 - 2016
  • LA State Medical License
    LA State Medical License 1996 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Antitumor efficacy of concurrent everolimus with hepatic transarterial bland embolization (evero-embo) in patients with metastatic well differentiated neuroendocrine t... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Sylvester Recruits Aman Chauhan, M.D., to Lead Neuroendocrine Tumor Program
    Sylvester Recruits Aman Chauhan, M.D., to Lead Neuroendocrine Tumor ProgramMarch 16th, 2023
  • Dedicated Neuroendocrine Tumors Program Launched at Sylvester Comprehensive Cancer Center
    Dedicated Neuroendocrine Tumors Program Launched at Sylvester Comprehensive Cancer CenterMarch 16th, 2023
  • UK Markey Cancer Foundation Funds First Professorship in Neuroendocrine Tumor Research
    UK Markey Cancer Foundation Funds First Professorship in Neuroendocrine Tumor ResearchMarch 29th, 2022
  • Join now to see all

Grant Support

  • Safety And Efficacy Of PTK787/ZK222584 In Patients With Neuroendocrine CancerNational Center For Research Resources2006
  • Study To Evaluate The Effect Of Age And Renal Function Of OctreoscanNational Center For Research Resources2005–2006
  • Study To Evaluate The Effect Of Age And Renal FunctionNational Center For Research Resources2004
  • Study Comparing Venofer Intravenously To NO Iron TxNational Center For Research Resources2004
  • Clinical Trial With Thymitaq Administered To PatientsNational Center For Research Resources2004
  • Iodine-131 Anti-B1 Antibody For NHLNational Center For Research Resources2000–2001
  • Therapeutic Indium 111 Pentetreotide In Somatostain Receptor Expressing CancersNational Center For Research Resources1998–2001
  • Vu Sando LAR 2 A Tolerability &Efficacy Of Multiple Doses Of SandostatinNational Center For Research Resources1996–1997
  • Comparative, 2 Way Crossover Multiple Dose Of Iv/Oral Regimen Of MesnaNational Center For Research Resources1996–1997
  • Phase I Study Of Somatuline In The Management Of Lung CancerNational Center For Research Resources1993–1997
  • Study Of Octreotide In The Management Of Neuroendocrine TumorsNational Center For Research Resources1992–1997
  • Routes Of Ifosfamide MetabolismNational Cancer Institute1996
  • Phase I Dosing Study Of Sandostatin LAR Given IM In Advanced CancerNational Center For Research Resources1995
  • Routes Of Ifosfamide MetabolismNational Cancer Institute1992–1995
  • Routes Of Ifosfamide MetabolismNational Center For Research Resources1993
  • Multiple Dose Urinary And Serum Pharmacokinetics Of Mesna And DimesnaNational Center For Research Resources1992–1993
  • Phase I Study Of Octreotide In The Management Of Neuroendocrine TumorsNational Center For Research Resources1991
  • Pharmacogenetic Aspects Of Cyclophosphamide MetabolismNational Center For Research Resources1988–1990

Professional Memberships